Alan E. Simon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alan E. Simon has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Jeannette Y. Lee
University of Arkansas for Medical Sciences, Little Rock, AR
2 shared publications - Jessica Snowden
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA
2 shared publications - Leslie W. Young
Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, USA
2 shared publications - Lori A. Devlin
Department of Pediatrics, University of Louisville School of Medicine, Louisville, USA
2 shared publications - Songthip Ounpraseuth
University of Arkansas for Medical Sciences, College of Medicine
2 shared publications - Abhik Das
RTI International, Rockville, Maryland, USA
1 shared publication
Latest Publications
- Open Access
- 21 December 2023
- Published by Springer Nature in Research Square
Error Rates of Data Processing Methods in Clinical Research: A Systematic Review and Meta-Analysis of Manuscripts Identified Through PubMed
Background: In clinical research, prevention of systematic and random errors of data collected is paramount to ensuring reproducibility of trial results and the safety and efficacy of the resulting interventions. Over the last 40 years, empirical assessments of data accuracy in clinical research have been reported in the literature. Although there have been reports of data error and discrepancy rates in clinical studies, there has been little systematic synthesis of these results. Further, although notable exceptions exist, little evidence exists regarding the relative accuracy of different data processing methods. We aim to address this gap by evaluating error rates for 4 data processing methods. Methods:A systematic review of the literature identified through PubMed was performed to identify studies that evaluated the quality of data obtained through data processing methods typically used in clinical trials: medical record abstraction (MRA), optical scanning, single-data entry, and double-data entry. Quantitative information on data accuracy was abstracted from the manuscripts and pooled. Meta-analysis of single proportions based on the Freeman-Tukey transformation method and the generalized linear mixed model approach were used to derive an overall estimate of error rates across data processing methods used in each study for comparison. Results: A total of 93 papers (published from 1978 to 2008) meeting our inclusion criteria were categorized according to their data processing methods. The accuracy associated with data processing methods varied widely, with error rates ranging from 2 errors per 10,000 fields to 2,784 errors per 10,000 fields. MRA was associated with both high and highly variable error rates, having a pooled error rate of 6.57% (95% CI: 5.51, 7.72). In comparison, the pooled error rates for optical scanning, single-data entry, and double-data entry methods were 0.74% (0.21, 1.60), 0.29% (0.24, 0.35) and 0.14% (0.08, 0.20), respectively. Conclusions: Data processing and cleaning methods may explain a significant amount of the variability in data accuracy. MRA error rates, for example, were high enough to impact decisions made using the data and could necessitate increases in sample sizes to preserve statistical power. Thus, the choice of data processing methods can likely impact process capability and, ultimately, the validity of trial results.
- 21 December 2023
- Published by Springer Nature in Research Square
Open AccessError Rates of Data Processing Methods in Clinical Research: A Systematic Review and Meta-Analysis of Manuscripts Identified Through PubMed
Background: In clinical research, prevention of systematic and random errors of data collected is paramount to ensuring reproducibility of trial results and the safety and efficacy of the resulting interventions. Over the last 40 years, empirical assessments of data accuracy in clinical research have been reported in the literature. Although there have been reports of data error and discrepancy rates in clinical studies, there has been little systematic synthesis of these results. Further, although notable exceptions exist, little evidence exists regarding the relative accuracy of different data processing methods. We aim to address this gap by evaluating error rates for 4 data processing methods. Methods:A systematic review of the literature identified through PubMed was performed to identify studies that evaluated the quality of data obtained through data processing methods typically used in clinical trials: medical record abstraction (MRA), optical scanning, single-data entry, and double-data entry. Quantitative information on data accuracy was abstracted from the manuscripts and pooled. Meta-analysis of single proportions based on the Freeman-Tukey transformation method and the generalized linear mixed model approach were used to derive an overall estimate of error rates across data processing methods used in each study for comparison. Results: A total of 93 papers (published from 1978 to 2008) meeting our inclusion criteria were categorized according to their data processing methods. The accuracy associated with data processing methods varied widely, with error rates ranging from 2 errors per 10,000 fields to 2,784 errors per 10,000 fields. MRA was associated with both high and highly variable error rates, having a pooled error rate of 6.57% (95% CI: 5.51, 7.72). In comparison, the pooled error rates for optical scanning, single-data entry, and double-data entry methods were 0.74% (0.21, 1.60), 0.29% (0.24, 0.35) and 0.14% (0.08, 0.20), respectively. Conclusions: Data processing and cleaning methods may explain a significant amount of the variability in data accuracy. MRA error rates, for example, were high enough to impact decisions made using the data and could necessitate increases in sample sizes to preserve statistical power. Thus, the choice of data processing methods can likely impact process capability and, ultimately, the validity of trial results.
- Open Access
- 9 August 2022
- Published by Springer Nature in Trials
- Vol. 23 (1) , 1-35
Eating, Sleeping, Consoling for Neonatal Opioid Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach study protocol for a multi-center, stepped-wedge randomized controlled trial
- 9 August 2022
- Published by Springer Nature in Trials
- Vol. 23 (1) , 1-35
Open AccessEating, Sleeping, Consoling for Neonatal Opioid Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach study protocol for a multi-center, stepped-wedge randomized controlled trial
- 1 June 2020
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 145 (6)
Adherence to Vitamin D Intake Guidelines in the United States
BACKGROUND: The American Academy of Pediatrics (AAP) revised its infant vitamin D intake guidelines in 2008. We aimed to examine previously unexplored trends in meeting vitamin D intake guidelines among US infants since 2009 and whether there were differences across demographic subgroups. METHODS: We analyzed dietary recall data for infants 0 to 11 months in the 2009–2016 NHANES. We estimated the percentage meeting 2008 AAP vitamin D guidelines, defined as consuming ≥1 L of infant formula and/or receiving a vitamin D supplement of ≥400 IU. We used Poisson regressions to assess trends over time and differences across demographic subgroups. RESULTS: Overall, 27.1% (95% confidence interval [CI]: 24.3%–29.8%) of US infants in 2009–2016 met vitamin D intake guidelines, with nonbreastfeeding infants (31.1% [95% CI: 27.6%–34.5%]) more likely to meet guidelines than breastfeeding infants (20.5% [95% CI: 15.4%–25.5%]; P < .01). From 2009–2010 to 2015–2016, overall and for both breastfeeding and nonbreastfeeding infants, there were no significant changes over time in the percentage of infants who met the guidelines (P > .05). Among breastfeeding infants, those with a family income ≥400% of the federal poverty level, with a college graduate head of household, and with private insurance were more likely to meet guidelines. CONCLUSIONS: Among US infants, we observed no increase in meeting AAP vitamin D intake guidelines since 2009. Less than 40% of infants met guidelines in nearly all demographic subgroups. These findings suggest renewed consideration of how to best meet vitamin D intake guidelines.
- 1 June 2020
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 145 (6)
Adherence to Vitamin D Intake Guidelines in the United States
BACKGROUND: The American Academy of Pediatrics (AAP) revised its infant vitamin D intake guidelines in 2008. We aimed to examine previously unexplored trends in meeting vitamin D intake guidelines among US infants since 2009 and whether there were differences across demographic subgroups. METHODS: We analyzed dietary recall data for infants 0 to 11 months in the 2009–2016 NHANES. We estimated the percentage meeting 2008 AAP vitamin D guidelines, defined as consuming ≥1 L of infant formula and/or receiving a vitamin D supplement of ≥400 IU. We used Poisson regressions to assess trends over time and differences across demographic subgroups. RESULTS: Overall, 27.1% (95% confidence interval [CI]: 24.3%–29.8%) of US infants in 2009–2016 met vitamin D intake guidelines, with nonbreastfeeding infants (31.1% [95% CI: 27.6%–34.5%]) more likely to meet guidelines than breastfeeding infants (20.5% [95% CI: 15.4%–25.5%]; P < .01). From 2009–2010 to 2015–2016, overall and for both breastfeeding and nonbreastfeeding infants, there were no significant changes over time in the percentage of infants who met the guidelines (P > .05). Among breastfeeding infants, those with a family income ≥400% of the federal poverty level, with a college graduate head of household, and with private insurance were more likely to meet guidelines. CONCLUSIONS: Among US infants, we observed no increase in meeting AAP vitamin D intake guidelines since 2009. Less than 40% of infants met guidelines in nearly all demographic subgroups. These findings suggest renewed consideration of how to best meet vitamin D intake guidelines.
- 1 June 2018
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 141 (6) , e20180920
Risk Markers and Intermediate Outcomes in Research and Clinical Practice
In adult cardiovascular disease, researchers have introduced a plethora of new imaging and biomarkers in hopes that these novel risk markers will either improve risk prediction for individuals, lend biological plausibility to modifying underlying behaviors or more aggressively treating traditional risk factors like blood pressure and lipids, or offer insights into pathophysiology that is amenable to drug therapy.1 One of these novel factors is retinal vessel diameters, which predict future cardiovascular outcomes, at least in women.2–4 In this issue of Pediatrics , Köchli et al5 examine retinal vessel diameters in children. They posit that physical activity, BMI, and blood pressure affect retinal vessel diameters, which reflect early signs of microvascular disease, which, in turn, leads to adult cardiovascular outcomes. With this article, we provide an opportunity to consider when novel risk factors are useful either in making clinical decisions or in research. Pediatric clinicians often use risk markers, by themselves or in combination with … Address correspondence to Alan E. Simon, MD, Environmental Influences on Child Health Outcomes Program, National Institutes of Health, 6011 Executive Blvd, Suite 325, Room 316, Rockville, MD 20852. E-mail: alan.simon{at}nih.gov
- 1 June 2018
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 141 (6) , e20180920
Risk Markers and Intermediate Outcomes in Research and Clinical Practice
In adult cardiovascular disease, researchers have introduced a plethora of new imaging and biomarkers in hopes that these novel risk markers will either improve risk prediction for individuals, lend biological plausibility to modifying underlying behaviors or more aggressively treating traditional risk factors like blood pressure and lipids, or offer insights into pathophysiology that is amenable to drug therapy.1 One of these novel factors is retinal vessel diameters, which predict future cardiovascular outcomes, at least in women.2–4 In this issue of Pediatrics , Köchli et al5 examine retinal vessel diameters in children. They posit that physical activity, BMI, and blood pressure affect retinal vessel diameters, which reflect early signs of microvascular disease, which, in turn, leads to adult cardiovascular outcomes. With this article, we provide an opportunity to consider when novel risk factors are useful either in making clinical decisions or in research. Pediatric clinicians often use risk markers, by themselves or in combination with … Address correspondence to Alan E. Simon, MD, Environmental Influences on Child Health Outcomes Program, National Institutes of Health, 6011 Executive Blvd, Suite 325, Room 316, Rockville, MD 20852. E-mail: alan.simon{at}nih.gov